Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
Launched by CITY UNIVERSITY OF NEW YORK · Oct 25, 2019
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help improve language skills in people who have chronic aphasia, a condition that affects speech and communication, often following a stroke. The researchers want to see if combining a specific type of brain stimulation called transcranial direct current stimulation (tDCS) with a language therapy called Verb Network Strengthening Treatment (VNeST) can make the therapy more effective. During the study, participants will receive this brain stimulation twice a week for eight weeks while they engage in language therapy.
To participate in this study, individuals must be right-handed and have had a stroke affecting the left side of their brain at least six months before joining. They should also have a high school education and be fluent in English. Healthy volunteers who match the age and education of the participants with aphasia are also welcome. Participants will undergo a screening to ensure they can complete the required tasks for the study. It's important to note that those with certain medical conditions, such as severe hearing or vision problems, or those who are pregnant, cannot participate. This trial is currently recruiting participants, and it's a great opportunity for those interested in improving language abilities after a stroke.
Gender
ALL
Eligibility criteria
- • This study recruits individuals with post-stroke aphasia as well as a group of healthy volunteers matched for age, sex, and education.
- INCLUSION Criteria:
- • Right handed (pre-stroke for participants with aphasia)
- • High school education or equivalent
- • Native English fluency without early 2nd language exposure (before age 10)
- • Ability to perform the required discourse and MRI tasks (determined via in-person screening)
- Additional INCLUSION Criteria for participants with APHASIA:
- • Single-event left hemisphere stroke \> 6 months prior to enrollment
- • Aphasia diagnosis per Western Aphasia Battery-Revised
- • Not receiving any other speech therapy for the entire study period (20 weeks)
- • Ability to perform the required therapy tasks (determined via in-person screening)
- EXCLUSION Criteria:
- • Failed vision or hearing screening
- • MRI contraindications (including pacemaker)
- • Pregnancy
- • History of seizure or change in seizure medication in past 12 months
- • History of speech/language, psychiatric, or neurological disorder, or current serious medical condition (except chronic stroke comorbidities for participants with aphasia)
- Additional EXCLUSION criteria for participants with APHASIA are:
- • Unmodifiable hair style precluding scalp contact by electrodes
- • Sensitive scalp by self-report
About City University Of New York
The City University of New York (CUNY) is a leading urban public university system dedicated to advancing education, research, and community service. Comprising 25 campuses across New York City, CUNY fosters a diverse and inclusive environment, empowering students and faculty to engage in innovative research and clinical trials that address critical health challenges. With a commitment to interdisciplinary collaboration and the application of scientific knowledge, CUNY actively contributes to the advancement of healthcare through rigorous clinical research, aiming to improve patient outcomes and enhance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baton Rouge, Louisiana, United States
New York, New York, United States
Patients applied
Trial Officials
E. Susan Duncan, PhD, CCC-SLP
Principal Investigator
City University of New York
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials